5:30 pm to 5:40 pm
Welcome & Logistics
W. Peter Wuelfing, Ph.D., Executive Director, Discovery Pharmaceutical Sciences , Merck & Ron L. Smith, Ph.D, FAAPS, Principle, Pharmawyze LLC
5:40 pm to 5:45 pm
Nasal drug delivery via Nose Plug® Technology
Peter Ahnblad, MD, Senior Consultant Physician, Hogne AB
5:45 pm to 5:50 pm
Innovative Solutions for Drug Delivery and Drug Substance Manufacturing
Derek Richards, Seqens
5:50 pm to 5:55 pm
PharmaShell® drug delivery system based Long Acting Injectables formulations
Joel Hellrup, PhD, Head of Pharmaceutical R&D, Nanexa AB
5:55 pm to 6:00 pm
NaDeNo’s polymer based drug delivery platform for oncology applications
Dr. Ruth Schmid, Strategic and Scientific Advisor, NaDeNo
6:00 pm to 6:05 pm
Model Based Drug Development Research (PBPK modeling)
Dan O’Connor, Senior Director, Business Development, Simulations Plus
6:05 pm to 6:15 pm
Break / Informal Networking #1
6:15 pm to 6:20 pm
Capabilities and Expertise in polymer based parenteral drug delivery for potent compounds
Rob Sterling, Director Business Development, Sever Pharma Solutions
6:20 pm to 6:25 pm
Tunable Extended-Release Capsules (TERC®) for intravitreal injection of biologic molecules prepared via electrospinning
Katelyn Swindle-Reilly, Chief Technology Officer, Vitranu, Inc., Associate Professor at the Ohio State University
6:25 pm to 6:30 pm - MeltPrep VCM (vacuum compression molding) for drug-eluting implants
Daniel Treffer, Founder, MeltPrep
6:30 pm to 6:35 pm
DEC Healthcare; enabling our global partners in hormone delivery
Nick Gaddum, PhD, Chief Scientific Officer, DEC Healthcare Ltd
6:35 pm to 6:40 pm
Apinovex and Apisolex polymers: new tools for solubility and bioavailability enhancement
Nick DiFranco, MEM, Global Market Manager – Oral Drug Delivery, Lubrizol Life Science Health
6:40 pm to 6:50 pm
Break / Informal Networking #2
6:50 pm to 6:55 pm
Formulation of RNA containing dry powders for inhalation therapy
Benjamin Winkeljann , CEO, RNHale
6:55 pm to 7:00 pm
ARCTM microfluidic, non-optical nanoparticle analysis systems.
Mark Ruane, Business Development, Spectradyne
7:00-pm to 7:05 pm
Shortening development cycles with microstructure-based prediction of drug release
Dr. Andrew Clark, Associate Director of Pharmaceutical Science, DigiM Solution
7:05 pm to 7:10 pm
Title TBD
Ali Shaukat, Sr. Director Scientific Affairs, Ascendia Bio
7:10 pm to 7:15 pm
Scaleable microparticles for Pharma applications
Micheal van Alst, CEO, IamFluidics
7:15 pm to 7:20 pm
Break / Informal Networking
For questions or further inquires please contact:
Stacy McManus, CEM
Senior Director, Industry Relations
smcmanus@controlledreleasesociety.org
856.380.6916